Utility of PCD Diagnostics to Improve Clinical Care

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1+
SponsorVanderbilt University Medical Center

About this trial

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

Eligibility criteria

Qualifiers

Referred to center for PCD diagnosis considerations

Ability to perform study procedures

Age greater than 2 years of age

Disqualifiers

Age less than 2 years of age Inability to perform informed consent

Trial design

Treatments tested in this trial

  • nNO testing

Treatment groups

200 Participants
are divided into 1 treatment group